Utkarsh Small Finance Bank Limited (NSE:UTKARSHBNK)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	237.01	4,976	4,045	614.62	1,118
Depreciation & Amortization	765.69	652.67	586.55	408.84	295.77
Gain (Loss) on Sale of Assets	-2.4	0.58	-	-0.63	0.21
Gain (Loss) on Sale of Investments	435.3	198.15	162.8	21.38	148.38
Provision for Credit Losses	8,099	3,421	2,988	4,201	2,668
Change in Other Net Operating Assets	-41,981	-37,940	-29,187	-17,424	-27,228
Other Operating Activities	21.31	943.27	776.55	-195.34	-561.19
Operating Cash Flow	-32,175	-27,712	-20,628	-12,375	-23,558
Capital Expenditures	-1,590	-704.13	-758.47	-1,467	-793.69
Sale of Property, Plant and Equipment	12.77	2.32	4.02	4.9	0.17
Investment in Securities	-6,192	-5,496	-6,177	-5,925	-4,531
Investing Cash Flow	-7,769	-6,198	-6,932	-7,387	-5,324
Long-Term Debt Issued	14,607	5,460	-	-	-
Total Debt Issued	14,607	5,460	-	-	-
Long-Term Debt Repaid	-11,010	-9,004	-2,225	-352.86	-653.64
Total Debt Repaid	-11,010	-9,004	-2,225	-352.86	-653.64
Net Debt Issued (Repaid)	3,597	-3,544	-2,225	-352.86	-653.64
Issuance of Common Stock	57.92	5,136	13.27	1,466	2,370
Common Dividends Paid	-550.23	-	-	-	-
Net Increase (Decrease) in Deposit Accounts	40,931	37,625	36,360	25,666	22,724
Other Financing Activities	-	-195.42	-141.34	-	-
Financing Cash Flow	44,036	39,021	34,007	26,780	24,440
Net Cash Flow	4,092	5,111	6,447	7,018	-4,442
Free Cash Flow	-33,765	-28,416	-21,387	-13,841	-24,352
Free Cash Flow Margin	-205.02%	-146.14%	-140.00%	-179.17%	-349.64%
Free Cash Flow Per Share	-31.34	-27.11	-23.82	-15.72	-31.83
Cash Income Tax Paid	-1,108	635.94	707.1	543.77	963.01

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.